Skip to main content
. 2020 Dec 4;11:605688. doi: 10.3389/fimmu.2020.605688

Table 4.

Comparison of HLA allele and haplotype frequencies between patients with pauci-symptomatic/mild (Group A) and moderate/severe disease (Group S).

Alleles/haplotypes Healthy controls (1238 alleles) Group A (286 alleles) Group S (78 alleles)
n (%) n (%) n (%) P OR (95% CI) Pc
HLA-A
A*23:01 20 (1.6) 0 4 (5.1) 0.002 > 2.5 0.034
A*69:01 0 2 (2.6) 0.045 > 0.7 0.765
HLA-B
B*07:02 or B*07:05 37 (3.0) 6 (2.1) 6 (7.7) 0.025 3.9 (1.0–14.9) 0.950
B*40:02 11 (0.9) 6 (2.1) 6 (7.7) 0.029 3.9 (1.2–12.4) 0.950
HLA-C
C*12:02, 12:03 77 (6.2) 34 (11.9) 2 (2.6) 0.010 0.2 (0.0–0.8) 0.120
HLA-DRB1
DRB1*08:01 23 (1.9) 0 4 (5.1) 0.002 > 2.5 0.024
DRB1*11:01, 11:02, 11:03, 11:04 195 (15.8) 42 (14.7) 4 (5.1) 0.022 0.3 (0.1–0.9) 0.252
DRB1*04:03 or DRB1*04:05 164 (13.2) 32 (11.2) 16 (20.5) 0.038 2.0 (1.0–4.1) 0.456
Haplotypes
HLA-A*02:05, B*58:01, C*07:01 107 (8.6) 12 (4.2) 0 0.077 0 (0–1.3) 1
HLA-A*30:02, B*14:02, C*08:02 13 (1.1) 4 (1.4) 10 (12.8) 5.9 · 10-5 10.3 (2.9–46.3) 0.022

Pc was obtained by multiplying the uncorrected P value by the number of alleles observed.

Results displaying a P or a Pc < 0.05 are in bold.